Elazzouzi Amy
SEC CIK 2042910 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| AURA | Aura Biosciences, Inc. | VP, Fin | 143.6K | — | $137.8K | 12 | 2024-10-29 | 2026-09-01 |
Most active insiders at AURA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Matrix Capital Management Company, LP | 10% | — | $39.04M |
| 2 | de los Pinos Elisabet | See Remarks, Dir | — | $380.8K |
| 3 | Hopkins Janet Jill | Chief Medical Off | — | $196.0K |
| 4 | Plavsic Mark | CTO | — | $157.5K |
| 5 | Kilroy Conor | See Remarks | — | $143.4K |
| 6 | Gibney Anthony S | See Remarks | — | $82.3K |
| 7 | Elazzouzi Amy | SVP, Fin, PAO | — | $56.6K |
| 8 | Kratz Erica | Chief Reg, Quality Off | — | — |
| 9 | Abu-Absi Susan | COO | — | — |
| 10 | Bitetti Teresa Marie | Dir | — | — |
Transactions 12
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-09-01 17:23 | 2026-09-01 | AURA | Aura Biosciences, Inc. | Elazzouzi Amy | SVP, Fin, PAO | A - Grant | $0.00 | +23.5K | 143.6K | +20% | $0 |
| D | 2026-03-03 | 2026-03-02 | AURA | Aura Biosciences, Inc. | Elazzouzi Amy | SVP, Fin | A - Grant | $0.00 | +44.5K | 120.1K | +59% | $0 |
| 2026-02-17 | 2026-02-17 | AURA | Aura Biosciences, Inc. | Elazzouzi Amy | SVP, Fin | S - Sale | $5.06 | -8,549 | 75.5K | -10% | -$43.3K | |
| 2026-01-20 | 2026-01-20 | AURA | Aura Biosciences, Inc. | Elazzouzi Amy | SVP, Fin | S - Sale | $4.86 | -1,581 | 84.1K | -2% | -$7,684 | |
| 2025-10-29 | 2025-10-29 | AURA | Aura Biosciences, Inc. | Elazzouzi Amy | SVP, Fin | S - Sale | $6.35 | -896 | 85.7K | -1% | -$5,690 | |
| DM | 2025-08-18 | 2025-08-18 | AURA | Aura Biosciences, Inc. | Elazzouzi Amy | SVP, Fin | M - OptEx | $3.96 | +12.9K | 92.0K | +16% | +$51.1K |
| D | 2025-08-18 | 2025-08-18 | AURA | Aura Biosciences, Inc. | Elazzouzi Amy | SVP, Fin | S - Sale+OE | $6.70 | -7,722 | 86.6K | -8% | -$51.7K |
| 2025-04-16 | 2025-04-16 | AURA | Aura Biosciences, Inc. | Elazzouzi Amy | SVP, Fin | S - Sale | $5.49 | -897 | 81.4K | -1% | -$4,925 | |
| 2025-02-18 | 2025-02-18 | AURA | Aura Biosciences, Inc. | Elazzouzi Amy | SVP, Fin | S - Sale | $7.75 | -1,404 | 82.3K | -2% | -$10.9K | |
| D | 2025-02-04 | 2025-02-03 | AURA | Aura Biosciences, Inc. | Elazzouzi Amy | SVP, Fin | A - Grant | $0.00 | +45.2K | 83.7K | +118% | $0 |
| 2025-01-21 | 2025-01-21 | AURA | Aura Biosciences, Inc. | Elazzouzi Amy | VP, Fin | S - Sale | $7.67 | -1,001 | 38.4K | -3% | -$7,678 | |
| 2024-10-29 | 2024-10-29 | AURA | Aura Biosciences, Inc. | Elazzouzi Amy | VP, Fin | S - Sale | $10.74 | -553 | 39.4K | -1% | -$5,939 |
Purchase Sale Sale after option exercise All abbreviations